Rilpivirine HydrochlorideMeSH concept

http://www.has-sante.fr/portail/jcms/c_2732128/fr/odefsey
http://www.has-sante.fr/portail/jcms/c_2732128/fr/odefsey-emtricitabine-rilpivirine-tenofovir-alafenamide-association-d-antiretroviraux
2016
false
false
false
France
French
evaluation of the transparency committee
tenofovir alafenamide
tenofovir alafenamide
guidelines for drug use
administration, oral
treatment outcome
insurance, health, reimbursement
reverse transcriptase inhibitors
reverse transcriptase inhibitors
anti-hiv agents
anti-hiv agents
hiv infections
emtricitabine, tenofovir alafenamide and rilpivirine
adult
adolescent
human immunodeficiency virus i infection
HIV-1
Emtricitabine
Emtricitabine
Rilpivirine Hydrochloride
Rilpivirine Hydrochloride
tenofovir alafenamide
tenofovir alafenamide
adenine
adenine
adenine
Rilpivirine
Rilpivirine

---
https://www.ema.europa.eu/medicines/human/EPAR/Odefsey
2016
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
emtricitabine, tenofovir alafenamide and rilpivirine
drug approval
europe
treatment outcome
Emtricitabine
Rilpivirine
tenofovir alafenamide
tenofovir alafenamide
drug combinations
product surveillance, postmarketing
adult
adolescent
hiv infections
HIV-1
human immunodeficiency virus i infection
administration, oral
reverse transcriptase inhibitors
reverse transcriptase inhibitors
anti-hiv agents
anti-hiv agents
prodrugs
risk assessment
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Rilpivirine Hydrochloride
Rilpivirine Hydrochloride
tenofovir alafenamide
Tenofovir
Emtricitabine
Rilpivirine
tenofovir alafenamide
adenine

---